Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -817 | -781 | -353 | -2,363 | -1,309 |
| Depreciation Amortization | N/A | N/A | N/A | 65 | 41 |
| Accounts payable and accrued liabilities | 45 | 42 | 2 | -29 | 40 |
| Other Working Capital | 796 | 637 | 283 | 848 | 360 |
| Other Operating Activity | -59 | 66 | 35 | 1,071 | 301 |
| Operating Cash Flow | $-35 | $-36 | $-33 | $-408 | $-569 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 6 | N/A | 188 | N/A |
| Debt Issued | 6 | N/A | 6 | 100 | 423 |
| Financing Cash Flow | $6 | $6 | $6 | $287 | $423 |
| Beginning Cash Position | 30 | 30 | 30 | 151 | 151 |
| End Cash Position | 0 | 0 | 2 | 30 | 5 |
| Net Cash Flow | $-30 | $-30 | $-28 | $-121 | $-146 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35 | -36 | -33 | -408 | -569 |
| Free Cash Flow | -35 | -36 | -33 | -408 | -569 |